V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004903 | 290003585 | 0 | 54.7 | Adjuvant (A) | 2017-05-09 | 2017-05-09 | LANREOTIDE | N | N | 290022000 | CISPLATIN + FLUOROURACIL |
| 290004904 | 290003586 | 1.68 | null | Palliative (P) | 2017-05-27 | 2017-05-29 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022003 | CAPECITABINE |
| 290004905 | 290003587 | 1.56 | 49.5 | Palliative (P) | 2015-11-11 | 2015-11-30 | ECX | N | N | 290022005 | LANREOTIDE |
| 290004906 | 290003588 | 1.8 | 85 | Palliative (P) | 2016-06-07 | 2016-06-12 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290022007 | CISPLATIN + FLUOROURACIL |
| 290004907 | 290003589 | null | 74.7 | Neo-adjuvant (N) | 2016-01-23 | 2016-02-20 | Cisplatin + Docetaxel +Fluorouracil | 02 | Y | 290022008 | CAPECITABINE |
| 290004908 | 290003590 | 1.74 | 60.6 | Curative (C) | 2014-03-13 | 2014-03-16 | LANREOTIDE | N | N | 290022010 | CAPECITABINE + RT |
| 290004909 | 290003591 | 1.6 | null | Disease modification (D) | 2018-02-25 | 2018-04-13 | Capecitabine + Cisplatin | N | N | 290022012 | CARBOPLATIN + VINORELBINE |
| 290004911 | 290003593 | null | 113 | Palliative (P) | null | 2015-11-01 | GemCarbo Days 1+8 | Y | N | 290022014 | CARBOPLATIN |
| 290004912 | 290006572 | 1.6 | 54.7 | Palliative (P) | 2018-01-07 | 2018-01-07 | MCX | 02 | N | 290022017 | CAPE + CARBOPLATIN + CETUXIMAB |
| 290004913 | 290006572 | 1.68 | 64.2 | Palliative (P) | 2013-11-12 | 2013-11-12 | ECF | 02 | N | 290022017 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004914 | 290003594 | 1.69 | 86.5 | null | 2016-03-01 | 2016-03-01 | EOX | N | null | 290022019 | CISPLATIN + FLUOROURACIL |
| 290004915 | 290003594 | 1.7 | null | Curative (C) | null | 2015-09-16 | Trial Unspecified | 99 | N | 290022019 | CARBOPLATIN + RT |
| 290004916 | 290003594 | 1.51 | 88 | Palliative (P) | 2014-08-14 | 2014-08-13 | Cetuximab + Radiotherapy Load | 01 | N | 290022019 | CAPECITABINE + CISPLATIN |
| 290004917 | 290003594 | 1.5 | null | Palliative (P) | 2013-10-18 | 2013-10-29 | Trial Unspecified | 02 | N | 290022019 | GEMCARBO |
| 290004918 | 290003595 | 1.73 | 0 | null | 2017-04-13 | 2017-04-15 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 290022026 | EOX |
| 290004919 | 290003595 | null | null | Adjuvant (A) | 2017-11-29 | 2017-12-01 | CYCLOPHOSPHAMIDE | N | N | 290022026 | CARBOPLATIN + ETOPOSIDE |
| 290004920 | 290007774 | 1.91 | 86.3 | Palliative (P) | 2013-12-09 | 2013-12-14 | Rituximab (Maintenance) | 2 | N | 290022030 | CETUXIMAB |
| 290004921 | 290003596 | 1.68 | 55.2 | Palliative (P) | 2013-07-27 | 2013-08-06 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 290022031 | EOX |
| 290004922 | 290003597 | 1.51 | null | Curative (C) | 2016-03-14 | 2016-03-21 | Fluorouracil + Folinic Acid (Mayo) | 02 | N | 290022034 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004923 | 290003598 | 1.74 | 89 | Neo-adjuvant (N) | 2015-01-16 | 2015-02-02 | Cisplatin + Docetaxel +Fluorouracil | Y | Y | 290022039 | CAPECITABINE + IRINOTECAN |
| 290004924 | 290003599 | null | null | null | 2015-03-06 | 2015-03-22 | Cisplatin +Fluorouracil (2 wk) | N | N | 290022042 | CAPECITABINE |
| 290004925 | 290003600 | 1.74 | 77.8 | Not known (9) | 2017-12-19 | 2017-12-19 | CETUXIMAB + RT | 02 | N | 290022043 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 290004926 | 290003601 | 1.57 | 54 | Neo-adjuvant (N) | 2013-12-11 | 2013-12-11 | Gemcitabine weekly | 2 | null | 290022044 | FLUOROURACIL + RT |
| 290004927 | 290003602 | null | null | Adjuvant (A) | 2017-10-10 | 2017-10-13 | Capecitabine | null | null | 290022047 | LANREOTIDE |
| 290004928 | 290003603 | 1.75 | 83.6 | Adjuvant (A) | 2015-10-24 | 2015-11-03 | LANREOTIDE | N | N | 290022051 | CISPLATIN + FLUOROURACIL |
| 290004929 | 290003604 | 0 | 80 | Curative (C) | 2015-12-13 | 2015-12-28 | ECX | 01 | Y | 290022052 | CETUXIMAB + RT |
| 290004930 | 290003605 | 1.78 | 110.2 | Palliative (P) | 2017-03-13 | 2017-03-20 | Ipilimumab | N | N | 290022053 | CISPLATIN + FLUOROURACIL |
| 290004931 | 290003606 | null | 78.2 | Neo-adjuvant (N) | null | 2017-01-13 | Capecitabine 35days + RT | N | N | 290022055 | SUNITINIB |
| 290004932 | 290003607 | null | null | Palliative (P) | 2014-04-16 | 2014-05-06 | CETUXIMAB + RT | N | N | 290022059 | LANREOTIDE |
| 290004933 | 290003607 | 1.7 | 82.5 | Palliative (P) | 2017-09-27 | 2017-09-28 | FLUOROURACIL | 02 | null | 290022059 | CISPLATIN + FLUOROURACIL |
| 290004934 | 290007775 | 1.65 | 38 | Palliative (P) | 2014-12-02 | 2014-12-22 | EOX | N | N | 290022062 | IPILIMUMAB |
| 290004935 | 290003608 | 1.6 | 64.5 | Palliative (P) | 2014-09-08 | 2014-09-27 | CETUXIMAB + RT | N | N | 290022063 | CAPECITABINE |
| 290004936 | 290003609 | 1.73 | 67.3 | Disease modification (D) | 2016-01-16 | 2016-01-24 | Irinotecan + Modified De Gramont | 02 | N | 290022064 | CETUXIMAB + RT |
| 290004938 | 290003611 | 1.71 | 79.2 | Palliative (P) | 2013-05-07 | 2013-05-07 | Cetuximab 7 day (>Cycle 2) | 02 | N | 290022066 | CAPECITABINE + RT |
| 290004939 | 290003612 | null | 71 | Not known (9) | 2016-02-27 | 2016-05-22 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 290022067 | CARBOPLATIN |
| 290004940 | 290003613 | null | 98 | Curative (C) | 2017-05-29 | 2017-06-27 | Capecitabine | null | N | 290022070 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004941 | 290003614 | 1.76 | null | Curative (C) | 2017-07-03 | 2017-07-09 | Cetuximab + Radiotherapy Load | 02 | Y | 290022072 | CARBOPLATIN + PACLITAXEL |
| 290004942 | 290003615 | null | null | Curative (C) | null | 2016-02-23 | Capecitabine | N | N | 290022074 | CISPLATIN + FLUOROURACIL |
| 290004943 | 290003616 | 1.56 | 75.3 | Curative (C) | 2015-10-24 | 2015-10-24 | LANREOTIDE | N | Y | 290022075 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004944 | 290003616 | null | 59 | Palliative (P) | 2018-05-11 | 2018-05-22 | Capecitabine + Streptozocin | 02 | N | 290022075 | CAPECITABINE |
| 290004945 | 290003616 | 1.73 | null | Curative (C) | 2013-11-06 | 2013-12-03 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 290022075 | ECARBOX |
| 290004946 | 290008198 | 1.72 | 85 | Disease modification (D) | 2015-09-06 | 2015-10-11 | CHOP R - 21 days | 01 | N | 290022079 | TRIAL |
| 290004947 | 290003617 | 1.75 | 72.2 | null | 2017-07-21 | 2017-07-21 | FLUOROURACIL | 2 | null | 290022080 | FLUOROURACIL |
| 290004948 | 290003618 | null | null | null | 2014-10-19 | 2014-10-19 | CISPLATIN + FLUOROURACIL | N | null | 290022081 | CARBOPLATIN + PEMETREXED |
| 290004949 | 290003619 | 1.66 | 58.6 | Adjuvant (A) | 2017-08-03 | 2017-08-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022085 | CISPLATIN + FLUOROURACIL + RT |
| 290004950 | 290003620 | null | 91 | Curative (C) | 2014-02-23 | 2014-03-21 | Cetuximab + Radiotherapy Load | N | Y | 290022087 | CISPLATIN + FLUOROURACIL |
| 290004951 | 290003621 | null | null | Palliative (P) | 2014-10-29 | 2014-11-15 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290022088 | CAPECITABINE + RT |
| 290004952 | 290003622 | 1.64 | 60.2 | Adjuvant (A) | 2017-12-25 | 2018-01-11 | Capecitabine | N | N | 290022089 | CARBOPLATIN + ETOPOSIDE |
| 290004954 | 290003624 | 1.63 | 68.2 | Palliative (P) | 2015-12-23 | 2015-12-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290022092 | ECARBOX |
| 290004955 | 290003625 | null | 65.8 | Curative (C) | 2016-11-21 | 2016-12-18 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | 290022093 | CARBOPLATIN |